Clinitech Lab

  • Market Cap: Micro Cap
  • Industry: Healthcare Services
  • ISIN: INE0QMR01015
  • NSEID:
  • BSEID: 544220
INR
34.89
0.00 (0.00%)
BSENSE

Jan 29

BSE+NSE Vol: 26400

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 10039331,
    "name": "Clinitech Lab",
    "stock_name": "Clinitech Lab",
    "full_name": "Clinitech Laboratory Ltd",
    "name_url": "stocks-analysis/clinitech-lab",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "34.89",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "34.89",
    "mcapval": "7.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 544220,
    "symbol": "",
    "ind_name": "Healthcare Services",
    "ind_code": 94,
    "indexname": "",
    "isin": "INE0QMR01015",
    "curr_date": "Jan 29",
    "curr_time": "",
    "bse_nse_vol": 26400,
    "exc_status": "Active",
    "traded_date": "Jan 29, 2026",
    "traded_date_str": "2026 01 29",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/clinitech-lab-10039331-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "How has been the historical performance of Clinitech Lab?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-clinitech-lab-3695839",
        "imagepath": "",
        "date": "2025-11-13 00:42:17",
        "description": "Answer:\nThe historical performance of Clinitech Lab shows a mixed trend in financial metrics over the past three years.\n\nBreakdown:\nClinitech Lab's net sales increased from 6.35 Cr in Mar'23 to 6.40 Cr in Mar'24, and further to 8.23 Cr in Mar'25, indicating a positive growth trajectory. Total operating income followed a similar pattern, reaching 8.23 Cr in Mar'25. However, total expenditure also rose significantly from 4.99 Cr in Mar'23 to 7.40 Cr in Mar'25, leading to a decline in operating profit (PBDIT) from 1.36 Cr in Mar'23 to 1.06 Cr in Mar'25. Profit before tax showed a decrease from 0.86 Cr in Mar'23 to 0.55 Cr in Mar'25, while profit after tax also fell from 0.61 Cr in Mar'23 to 0.39 Cr in Mar'25. Despite these declines, earnings per share (EPS) decreased from 4.07 in Mar'23 to 1.71 in Mar'25. On the balance sheet, total assets grew from 5.88 Cr in Mar'23 to 10.55 Cr in Mar'25, with total liabiliti..."
      },
      {
        "title": "When is the next results date for Clinitech Lab?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-clinitech-lab-3687265",
        "imagepath": "",
        "date": "2025-11-10 23:16:45",
        "description": "The next results date for Clinitech Lab is scheduled for 12 November 2025...."
      }
    ],
    "total": 97,
    "sid": "10039331",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/clinitech-laboratory-10039331"
  },
  "announcements": [
    {
      "caption": "Board Meeting Outcome for Outcome Of 08Th Board Meeting For FY 2025-26 Thorugh Video Conferencing",
      "datetime": "27-Jan-2026",
      "details": "Outcome of 08th Board meeting for FY 2025-26 through video conferencing without intimation for the following agendas: Approved the formation of a subsidiary of the company; To consider and approve re-constitution of Internal Complaint Committee (ICC) and revision in POSH Policy thereto",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "09-Jan-2026",
      "details": "Certificate under Reg 74(5) of SEBI (DP) Regulations for the quarter ended December 31 2025",
      "source": "BSE"
    },
    {
      "caption": "General Update W.R.T Incorporation Of Subsidiary Of The Company",
      "datetime": "19-Dec-2025",
      "details": "Disclosure under Regulation 30 of SEBI (LODR) Regulations 2015 w.r.t Incorporation of Subsidiary of the company",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock-recommendationAnnouncement

Board Meeting Outcome for Outcome Of 08Th Board Meeting For FY 2025-26 Thorugh Video Conferencing

27-Jan-2026 | Source : BSE

Outcome of 08th Board meeting for FY 2025-26 through video conferencing without intimation for the following agendas: Approved the formation of a subsidiary of the company; To consider and approve re-constitution of Internal Complaint Committee (ICC) and revision in POSH Policy thereto

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

09-Jan-2026 | Source : BSE

Certificate under Reg 74(5) of SEBI (DP) Regulations for the quarter ended December 31 2025

General Update W.R.T Incorporation Of Subsidiary Of The Company

19-Dec-2025 | Source : BSE

Disclosure under Regulation 30 of SEBI (LODR) Regulations 2015 w.r.t Incorporation of Subsidiary of the company

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available